Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ:UTHR) develops and commercializes medications for chronic lung diseases and ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...

Liquidia faced significant legal challenges from United Therapeutics ... LQDA was just about to submit an NDA for its PAH (pulmonary arterial hypertension) product candidate, an inhaled ...

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary ... Keros Therapeutics, Liquidia, Novartis, Respira Therapeutics, Roivant Sciences, and United Therapeutics.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

United Therapeutics Corporation ... injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of ...

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension ... Janssen Pharmaceuticals, Keros Therapeutics, Liquidia, Novartis, Respira Therapeutics, ...

United Therapeutics Corporation (NASDAQ ... Its products include treatments for pulmonary arterial hypertension (PAH), such as Tyvaso, Remodulin, and Orenitram, as well as a monoclonal antibody ...

Cerity Partners LLC grew its position in shares of United Therapeutics Co ... injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise ...

Silver Spring, MD-based United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of ...